InMed Pharmaceuticals Inc.INMNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.1%
5Y CAGR+7.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+11.1%/yr
vs -0.7%/yr prior
5Y CAGR
+7.6%/yr
Recent acceleration
Acceleration
+11.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.01M | +22.2% |
| 2025 | $6.56M | +13.1% |
| 2024 | $5.80M | -0.8% |
| 2023 | $5.85M | -14.8% |
| 2022 | $6.87M | +23.7% |
| 2021 | $5.55M | +75.9% |
| 2020 | $3.16M | -47.4% |
| 2019 | $6.00M | +16.2% |
| 2018 | $5.17M | +85.2% |
| 2017 | $2.79M | - |